10x Genomics Q3 EPS $(0.79), Sales $153.64M Beat $151.26M Estimate
Portfolio Pulse from Benzinga Newsdesk
10x Genomics reported Q3 losses of $(0.79) per share, missing the analyst consensus estimate of $(0.46) by 71.74%. However, the company's quarterly sales of $153.64M beat the estimate of $151.26M by 1.58%. This represents a 17.22% increase over sales from the same period last year.
November 02, 2023 | 8:55 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
10x Genomics' Q3 earnings per share missed estimates, but sales exceeded expectations.
10x Genomics reported a larger than expected loss per share, which could negatively impact the stock. However, the company's sales beat estimates, which could offset the negative impact of the earnings miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100